药物发现,开发和制造

关键字：类型：

下载页码(大于0,小于15961)：

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

药物发现,开发和制造 499条(本栏目收费,不能显示细节,电话13136136841)

RADIOPHARMACEUTICALS AND MEDICAL IMAGING: DEVELOPMENT OF RADIOIMMUMOCONJUGATES FOR RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY OF MALIGNANT DISEASES 14478

THERAPEUTIC DRUG DEVELOPMENT FOR KIDNEY DISEASES 14500

TARGETING CHEMOKINES AND ANGIOGENESIS IN RHEUMATOID ARTHRITIS * 14526

DEVELOPMENT OF THERAPEUTIC AGENTS: METHODS AND APPROACHES IN THE DEVELOPMENT OF VACCINES AGAINST PROTOZOAN PARASITES 14548

TOXICOLOGY 14562

DEVELOPMENT OF PHOSPHODIESTERASE 4 INHIBITORS FOR ALLERGIC AND NONALLERGIC INFLAMMATORY DISEASES OF THE AIRWAYS 14574

DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS: A JOURNEY JUST BEGINNING 14592

PHARMACOKINETIC AND PHARMACODYNAMIC-BASED DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 14596

DRUG INTERACTION ASSESSMENT STRATEGIES: SMALL MOLECULES VERSUS THERAPEUTIC PROTEINS 14630

MODEL-INDEPENDENTAND MODELBASED METHODS TO ASSESS DRUG–DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 14654

UTILITY OF IN VITRO METHODS IN DRUG–DRUG INTERACTION ASSESSMENTAND PREDICTION FOR THERAPEUTIC BIOLOGICS 14664

USE OF ANIMAL MODELS FOR PROJECTION OF CLINICAL DRUG–DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 14694

THE COCKTAIL APPROACH AND ITS UTILITY IN DRUG–DRUG INTERACTION ASSESSMENTS FOR THERAPEUTIC PROTEINS 14702

LOGISTIC CONSIDERATIONS IN STUDY DESIGN FOR BIOLOGIC DRUG–DRUG INTERACTION ASSESSMENTS 14710

STATISTICAL CONSIDERATIONS IN ASSESSING DRUG–DRUG INTERACTIONS FOR THERAPEUTIC BIOLOGICS 14730

SCIENTIFIC PERSPECTIVES ON THERAPEUTIC PROTEIN DRUG–DRUG INTERACTION ASSESSMENTS 14746

DISEASE–DRUG–DRUG INTERACTION ASSESSMENTS FOR TOCILIZUMAB—A MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR TO TREAT PATIENTS WITH RHEUMATOID ARTHRITIS 14782

DRUG–DRUG INTERACTIONS FOR ETANERCEPT—A FUSION PROTEIN 14798

DRUG INTERACTIONS OF CYTOKINES AND ANTICYTOKINE THERAPEUTIC PROTEINS 14806

DRUG INTERACTIONS FOR GROWTH FACTORS AND HORMONES 14830

DRUG–DRUG INTERACTIONS FOR NUCLEIC ACID-BASED DERIVATIVES 14848

MONOGRAPHS FOR DRUG-DRUG INTERACTIONS OF THERAPEUTICS BIOLOGICS 14866

TUMOR-TARGETED NANOPARTICLES: STATE-OF-THEART AND REMAINING CHALLENGES 14942

APPLICATIONS OF LIGANDENGINEERED NANOMEDICINES 14962

LIPID NANOPARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS 14992

PHOTOSENSITIVE LIPOSOMES AS POTENTIAL TARGETED THERAPEUTIC AGENTS 15022

MULTIFUNCTIONAL DENDRITIC NANOCARRIERS: THE ARCHITECTURE AND APPLICATIONS IN TARGETED DRUG DELIVERY 15042

CHITOSAN-BASED NANOPARTICLES FOR BIOMEDICAL APPLICATIONS 15070

POLYMER–DRUG NANOCONJUGATES 15092

NANOCRYSTALS PRODUCTION, CHARACTERIZATION, AND APPLICATION FOR CANCER THERAPY 15124

最新招商产品更多>>